Goeman, Carly J. “The Price Isn’t Right: Shareholder Proposals As Opportunities for Institutional Investors to Restore Firm Value and Reduce Pharmaceutical Prices”. Columbia Business Law Review 2017, no. 2 (August 11, 2017): 748–806. Accessed June 30, 2024. https://journals.library.columbia.edu/index.php/CBLR/article/view/1723.